What is lactoferrin and why does it matter for skin?

Lactoferrin is a protein found abundantly in human breast milk and bovine colostrum. It binds iron, which starves bacteria of a nutrient they need to multiply. For skin, it also helps regulate immune responses, support the moisture barrier, and reduce inflammation. Traditionally sourced from animal dairy, it can now be produced via precision fermentation without animal involvement.

What does precision fermentation actually mean?

Precision fermentation programs food-grade yeast with genetic instructions to produce a specific protein. The yeast grows in stainless-steel tanks, secretes the target protein, and that protein is then isolated and purified. The process runs independently of livestock farming and can be tightly controlled for purity and consistency.

Should I look for lactoferrin in skincare products now?

All G launched a bovine lactoferrin powder in 2025 and plans to release a human-identical version in early 2026, with regulatory approval already in place for China, Japan, and South Korea. However, current data is preclinical (cell and early-stage testing), meaning the results in human skin may differ. Watch for brands incorporating LFX into serums or treatments over the next one to two years as clinical data matures.

Lactoferrin Brewed in a Tank, Not Milked from a Cow

The conversation about where cosmetic ingredients come from is changing. Not just in terms of sustainability, but at the level of molecular design. Australian biotech company All G is making that conversation concrete with new preclinical data on a precision-fermented protein called lactoferrin LFX.

Fermentation as a Sourcing Strategy

Lactoferrin has been known to scientists for decades. It shows up in high concentrations in human breast milk and bovine colostrum, where it plays a central role in newborn immunity and antimicrobial defense. The protein binds iron with exceptional affinity, effectively starving bacteria of the nutrient they need to proliferate. In skin, researchers have observed benefits ranging from anti-inflammatory activity to barrier support.

The catch has always been supply. Extracting lactoferrin from dairy involves collecting large volumes of colostrum, then running it through multi-step purification processes where yield is variable and quality depends on the animal source.

All G’s approach skips that entirely. The company programs food-grade yeast with the genetic instructions to produce bovine or human milk proteins, then cultures that yeast in stainless-steel bioreactors. “The yeast grows in stainless-steel tanks, secretes the protein, and we isolate it,” says founder and CEO Jan Pacas. The result is LFX, a lactoferrin produced without a single cow or any collection of human milk.

What the Preclinical Data Shows

All G has now released results from preclinical testing, meaning experiments conducted in cell cultures rather than in human subjects. Four findings stand out.

Inflammatory cytokine levels dropped by 25%. Cytokines are signaling proteins that coordinate immune responses in skin. When the immune system overreacts, as it does in acne or psoriasis, cytokine activity drives redness, swelling, and tissue damage. A 25% reduction suggests LFX may help moderate that response at the cellular level.

Collagen production was stimulated by 30 to 40%. Collagen is the structural protein responsible for skin firmness and elasticity. The figure represents an increase in cellular synthesis, not topical delivery of collagen itself.

Beta-galactosidase activity was lowered. This enzyme accumulates in cells that have entered senescence, a state in which the cell stops dividing and begins to impair surrounding tissue. Reducing its activity is considered a marker of slowed cellular aging.

Filaggrin and AQP3 gene expression were upregulated. Filaggrin is a key structural protein in the outermost skin layer, essential for maintaining the moisture barrier. AQP3 (aquaporin-3) is a water channel protein that regulates how skin cells transport and retain moisture. Both are central to skin hydration and barrier integrity.

The intended application areas span hydration, barrier strengthening, acne lesion reduction, sebum control, and psoriasis support.

Regulatory Status and Market Timeline

All G has already secured regulatory compliance for LFX in China, Japan, and South Korea, three of the most demanding regulatory environments for cosmetic ingredients in Asia. A bovine lactoferrin powder launched in 2025. Human lactoferrin is scheduled for early 2026.

For brands, the precision fermentation pathway offers something animal-derived sourcing cannot: consistent molecular output across batches, year-round availability, and a supply chain that sidesteps the welfare and traceability concerns attached to animal agriculture. Vegan certification is also within reach, which matters for a growing segment of the market.

One Important Caveat

Dr. David Orchard, a dermatologist at the Royal Children’s Hospital in Melbourne, has reviewed the data and offered a measured response. He describes the results as “very preliminary.” That qualifier matters. Preclinical findings regularly fail to replicate at the same magnitude in clinical trials with human participants. Skin is a complex biological system, and cell-culture results represent one layer of that complexity.

What the data does establish is a starting point worth watching. Precision fermentation as a manufacturing technology has already proven itself in the food industry, where companies use the same yeast-based approach to produce proteins that would otherwise require animal sourcing. Moving that infrastructure into cosmetics is a logical extension, and All G is among the first to publish structured data on what it produces for skin.

The ingredient supply chain for skincare is in the middle of a slow but significant shift. Lactoferrin LFX is one early signal of where it is heading.

Source: Personal Care Insights